• 8 March 2012
  • News
  • By

BioSpectrum Technology Forum: February 24, 2012 @ Delhi

Sessions & Panelists
A perspective on R&D direction setting: Dr VK Vinayak, Industry Expert & CSO Biologicals, Panacea Biotec

Stem Cells & Gene Therapy (Trends and Policies): Dr Mrinalini Chaturvedi, Director, Cryo Banks International; Dr Alka Sharma, Jt Director, Department of Biotechnology; Dr Venkatesh Ponemone, Director, Laboratory and Clinical Research Affairs, Fortis- Totipotentrx Centrer for Cellular Medicine

Next Generation Innovation: Dr Geetha Vani Rayasam, Open Source Drug Discovery, CSIR; Dr VK Vinayak, CSO-Biologicals, Panacea Biotec; Dr Navin Khanna, Group Leader, Gene Recombinant Lab, ICGEB; Dr Alok Adholeya, Director of Biotechnology & Bioresources Division, The Energy and Resources Institute (TERI)

Bringing Technology/ Enabling Science: Dr VL Ramprasad, Chief Scientist- Genomics, Spinco

Public Private Partnerships: A case for excellence: Mr Pankaj Sharma, CEO, LeadInvent; Parul Saxena & Javed Ahmad, Jamia Hamdard Universitry Team; Dr Jitendra Verma, MD, Lifecare Innovations, Dr Ravi Dhar, Senior Consultant, BIRAP, DBT

Computer-aided Drug Discovery: Dr B Jayaram, Head-Computational Biology, IIT, Delhi; Mr Sahil Kapoor, CEO, Novo Informatics; Prof. Indira Ghosh, Dean, School of Computational and Integrative Sciences, Jawahar Lal Nehru University, Mr Pankaj Sharma, CEO, LeadInvent
BioSpectrum Technology Forum 2012 (BSTF) in Delhi saw the industry leaders getting together on the theme: “Game Changers in Drug Discovery & Development”. This was the third leg of the one-day BSTF series that brings together R&D leaders of the bioscience industry. The first two legs of the series were held in Bangalore and Mumbai, respectively. The sessions spanned diverse topics ranging from stem cells and gene therapy, to next generation innovation, public private partnerships, and computer-aided drug discovery.

The discussion on public private partnerships was an addition to the Forum agenda keeping in view the role such partnerships are playing in taking the industry further and its enormous potential. The panel discussion on “public private partnerships” was chaired by Dr Ravi Dhar, Senior Consultant, BIRAP, DBT.

The conference was opened by Dr Renu Swarup, Senior Adviser, Department of Biotechnology, who in her opening address elaborated on the BIRAP initiatives for the industry and how industry can benefit from these. Dr VK Vinayak, an industry veteran and CSO, Biologicals at Panacea Biotec, gave his perspective on the research direction the industry needs to take and also tied-up and summarized the key points from the industry. The industry leaders shared their perspective and insights across the range of topics. Many of you missed the action. However, we are not putting in a full report here, it will be available on our website, in a month or so, when the BioSpectrum new online platform goes live.

BSTF 2012 at Delhi was supported by: Department of Biotechnology, Government of India, and Spinco Biotech.

Dsc0013 Nandita Singh, Editor, BioSpectrum, welcomes the panelists and delegates
Dsc0029 Dr VK Vinayak, industry expert & CSO Biologicals, Panacea Biotec, and a panelist at the event, sets the tone for discussion
Dsc0022 Dr Renu Swarup, Sr Advisor, DBT, gives the inaugural address
BSTF Panelists @ Random
Dsc0039panalist Dr Venkatesh Ponemone, Fortis- Totipotentrx Centre for Cellular Medicine
Dsc0046panalist Dr Mrinalini Chaturvedi, Cryo Banks International
Dsc0054panalist Dr Alka Sharma, Department of Biotechnology
Dsc0079 Dr Navin Khanna, Gene Recombinant Lab, ICGEB
Dsc0085 Dr Geetha Vani Rayasam, Open Source Drug Discovery, CSIR
Dsc0090 Dr Alok Adholeya, The Energy and Resources Institute (TERI)
Dsc0103 Dr VL Ramprasad, Spinco
Dsc0104 Dr Ravi Dhar, BIRAP, DBT
Dsc0107 Jitendra Verma, Lifecare Innovations
Dsc0118 Mr Pankaj Sharma, LeadInvent
Dsc0121 Parul Saxena, Jamia Hamdard University
Dsc0139 Mr Sahil Kapoor, Novo Informatics
Dsc0141 Dr B Jayaram, IIT, Delhi
Dsc0153 Prof Indira Ghosh, Jawahar Lal Nehru University

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X